evidencegaps
Primary study · included by 1 review

Inhibitory Effects of Extracellular Vesicles from iPS-Cell-Derived Mesenchymal Stem Cells on the Onset of Sialadenitis in Sjögren's Syndrome Are Mediated by Immunomodulatory Splenocytes and Improved by Inhibiting miR-125b.

Zhao 2023 · Zhao Qingguo, Bae Eun-Hye, Zhang Yu, et al. · International journal of molecular sciences · 2023

Included by

The Efficacy of Mesenchymal Stem Cell-Based Therapy for Sjögren's Syndrome: A Systematic Review and Meta-Analysis of Preclinical Studies.
Non-Cochrane · intervention · 2026 · cited as Zhao 2023 · Table; Reference list; Supplementary Data 2

The review does not say which of its outcomes this study informs.

1 including review in total.